News
CMND
2.800
+6.87%
0.180
Clearmind Medicine Completes Enrollment For Second Cohort Of Phase I/IIa AUD Trial Of CMND-100
Benzinga · 2d ago
Clearmind Medicine Completes Second Cohort Enrollment in Phase I/IIa Trial for Alcohol Use Disorder Drug
Reuters · 2d ago
CLEARMIND MEDICINE ANNOUNCES SUCCESSFUL COMPLETION OF SECOND COHORT ENROLLMENT IN ONGOING FDA-APPROVED PHASE I/IIA TRIAL FOR CMND-100
Reuters · 2d ago
Weekly Report: what happened at CMND last week (1208-1212)?
Weekly Report · 3d ago
Clearmind Medicine Inc trading halted, news pending
TipRanks · 5d ago
Clearmind Medicine announces publication of review of MEAI
TipRanks · 6d ago
Clearmind Medicine Regains Nasdaq Compliance Amid Equity Rule Scrutiny
Reuters · 6d ago
CLEARMIND MEDICINE SUCCESSFULLY REGAINS COMPLIANCE WITH NASDAQ'S MINIMUM STOCKHOLDERS' EQUITY REQUIREMENT
Reuters · 6d ago
Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment
Barchart · 6d ago
Why Planet Labs Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Benzinga · 12/11 10:05
Clearmind Medicine To Implement 1-for-40 Reverse Stock Split Next Week
NASDAQ · 12/11 09:44
Why Did Clearmind Medicine Shares Plunge 29% After Hours?
Benzinga · 12/11 08:28
*Clearmind Medicine Announces 1-For-40 Reverse Shr Split >CMND
Dow Jones · 12/10 21:39
Clearmind Medicine to enact 1-for-40 reverse share split; shares down
Seeking Alpha · 12/10 21:20
Clearmind Medicine Announces 1-for-40 Reverse Stock Split
Reuters · 12/10 21:15
CLEARMIND MEDICINE ANNOUNCES 1-FOR-40 REVERSE SHARE SPLIT
Reuters · 12/10 21:15
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 12/09 21:07
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 12/09 12:05
Weekly Report: what happened at CMND last week (1201-1205)?
Weekly Report · 12/08 09:38
Clearmind Medicine announces receipt of Nasdaq minimum bid price notification
Seeking Alpha · 12/05 22:09
More
Webull provides a variety of real-time CMND stock news. You can receive the latest news about Clearmind Medici through multiple platforms. This information may help you make smarter investment decisions.
About CMND
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.